218 related articles for article (PubMed ID: 10974337)
1. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.
Kosch A; Junker R; Kurnik K; Schobess R; Günther G; Koch H; Nowak-Göttl U
Thromb Res; 2000 Sep; 99(6):531-7. PubMed ID: 10974337
[TBL] [Abstract][Full Text] [Related]
2. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.
Münchow N; Kosch A; Schobess R; Junker R; Auberger K; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S109-12. PubMed ID: 10650847
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
[TBL] [Abstract][Full Text] [Related]
4. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
[TBL] [Abstract][Full Text] [Related]
5. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.
von Depka M; Nowak-Göttl U; Eisert R; Dieterich C; Barthels M; Scharrer I; Ganser A; Ehrenforth S
Blood; 2000 Nov; 96(10):3364-8. PubMed ID: 11071628
[TBL] [Abstract][Full Text] [Related]
6. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
Nowak-Göttl U; Sträter R; Kosch A; von Eckardstein A; Schobess R; Luigs P; Nabel P; Vielhaber H; Kurnik K; Junker R
Eur J Haematol; 2001 Jan; 66(1):57-62. PubMed ID: 11168509
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.
Günther G; Junker R; Sträter R; Schobess R; Kurnik K; Heller C; Kosch A; Nowak-Göttl U;
Stroke; 2000 Oct; 31(10):2437-41. PubMed ID: 11022077
[TBL] [Abstract][Full Text] [Related]
8. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch HG; Schuierer G; von Eckardstein A
Blood; 1999 Dec; 94(11):3678-82. PubMed ID: 10572079
[TBL] [Abstract][Full Text] [Related]
10. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
[TBL] [Abstract][Full Text] [Related]
11. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
12. Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study.
Heidenreich S; Junker R; Wolters H; Lang D; Hessing S; Nitsche G; Nowak-Göttl U
J Am Soc Nephrol; 2003 Jan; 14(1):234-9. PubMed ID: 12506156
[TBL] [Abstract][Full Text] [Related]
13. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.
Knöfler R; Siegert E; Lauterbach I; Taut-Sack H; Siegert G; Gehrisch S; Müller D; Rupprecht E; Kabus M
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S147-50. PubMed ID: 10650856
[TBL] [Abstract][Full Text] [Related]
15. Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses.
Albisetti M; Moeller A; Waldvogel K; Bernet-Buettiker V; Cannizzaro V; Anagnostopoulos A; Balmer C; Schmugge M
Acta Haematol; 2007; 117(3):149-55. PubMed ID: 17159337
[TBL] [Abstract][Full Text] [Related]
16. Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study.
Nowak-Göttl U; Kotthoff S; Hagemeyer E; Junker R; Kehl HG; Vielhaber H; Kececioglu D
Thromb Res; 2001 Jul; 103(2):93-101. PubMed ID: 11457466
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
19. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
